BIO vs PLUR · rev $651.0M vs rev $1.3M
BIO (BIO) versus Pluri Inc. (PLUR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Pluri Inc. (PLUR) is a biotechnology company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported PLUR revenue for 2025-06-30 was $1.3M. Net income was -$23.3M. PLUR currently screens at market cap $24.3M.
BIO currently screens at market cap $0. PLUR currently screens at market cap $24.3M.
Not investment advice. Open the BIO and PLUR stock pages for the full models.
Not investment advice.